Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical study
3
×
democrats
3
×
detroit blog main
detroit top stories
fda
life sciences
national
national blog main
3
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
3
×
san francisco blog main
san francisco top stories
scott gottlieb
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
approval
car-t
celgene
commissioner
crispr
donald trump
eli lilly
failure
gene editing
glaxosmithkline
indiana blog main
What
bio
crispr
roundup
airport
allogene
annual
apocalypse
beds
big
bosley's
bosley’s
bridge
bucks
cancer
cas
celgene
ceo
crime
days
departure
diversity
editas
exit
fallout
gone
guiding
home
hot
immunotherapy
investors
ipo
j.p
jpm
juno
katrine
medicine
million
moves
nearly
new
Language
Current search:
democrats
×
" clinical study "
×
" san diego top stories "
×
" national blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More